Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 8, 2021

Primary Completion Date

June 25, 2024

Study Completion Date

June 27, 2024

Conditions

PTSD

Interventions

DRUG

Midomafetamine

120 mg midomafetamine HCl followed by a supplemental dose of 60 mg

BEHAVIORAL

Psychotherapy

Manualized psychotherapy performed by therapist team

Trial Locations (1)

James J. Peters VA Medical Center, The Bronx